parthenolide has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, S; Han, Y; Li, L; Liu, D; Liu, L; Qin, T; Ren, X; Zhang, H | 1 |
| Arai, Y; Inoue, H; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Oka, D; Okuyama, A; Shiba, M; Takayama, H | 1 |
2 other study(ies) available for parthenolide and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Parthenolide inhibits the tumor characteristics of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Neoplastic Stem Cells; Sesquiterpenes; Snail Family Transcription Factors | 2021 |
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-8; Lactones; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; NF-kappa B; Phosphorylation; Sesquiterpenes; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |